rich 1.0 hVIVO has been selected to run the world’s first pivotal Phase III human challenge trial in whooping cough, marking a major scientific milestone and its largest study to date. The contract strengthens revenue visibility into 2026–27 while underlining the growing importance of human challenge trials in accelerating vaccine approvals globally. The Vox Markets Podcast https://audioboom.com/channels/5051662-the-vox-markets-podcast Audioboom https://audioboom.com 480 95 https://audioboom.com/i/43608856/600x600/c 600 600 <iframe width="100%" height="95" src="https://embeds.audioboom.com/posts/8893869/embed?v=202301" style="background-color: transparent; display: block; padding: 0; width: 100%" frameborder="0" allowtransparency="allowtransparency" scrolling="no" title="Audioboom player" allow="autoplay" sandbox="allow-downloads allow-forms allow-popups allow-same-origin allow-scripts allow-storage-access-by-user-activation allow-top-navigation-by-user-activation"></iframe>